Delivery Order SPE2DR25D9227-SPE2DR26FFLP5
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA Pen 30 mg/mL. The delivery order, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a $9,975 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. This delivery order, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA Pen 30 mg/mL. The delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, carries no set-aside designation, indicating the awardee competed successfully in unrestricted federal procurement. This delivery order was issued under...
- The Defense Logistics Agency awarded a $19,950 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group is performing work at its Park Ridge facility and...
- The Defense Logistics Agency awarded a delivery order valued at $24,937.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency issued a delivery order valued at $14,962.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency awarded a $4,987.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite...
- The Defense Logistics Agency awarded a $13,167 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award was issued on January 22, 2026, with an ultimate completion date of January 23, 2026, under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, IL location. This delivery order represents...
- The Defense Logistics Agency awarded a $12,468.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The award, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/mL. The award was issued on January 29, 2026, with an ultimate completion date of January 30, 2026, under a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery...
- SPE2DR25D9227Indefinite Delivery Contract
- SPE2DR25D9227-SPE2DR26FFLP5Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,975.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. The award, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, indicating the contractor competed on an unrestricted basis. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that serves as the contracting vehicle for pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy designed to consolidate pharmaceutical and medical consumable sourcing across the federal military medical system. DMS Pharmaceutical Group, registered in the System for Award Management since 2001, has demonstrated substantial federal contracting capability through numerous delivery orders spanning oncology treatments, biologics, vaccines, specialty pharmaceuticals, and routine medications. As one of multiple regional prime vendor contractors under this initiative, the company is positioned to fulfill diverse pharmaceutical requirements supporting DoD healthcare operations globally, with delivery orders structured as firm fixed-price arrangements to ensure cost predictability for recurring medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 1/28/26 |